Bonna Ith

1.5k total citations
14 papers, 1.2k citations indexed

About

Bonna Ith is a scholar working on Molecular Biology, Cancer Research and Critical Care and Intensive Care Medicine. According to data from OpenAlex, Bonna Ith has authored 14 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 4 papers in Cancer Research and 3 papers in Critical Care and Intensive Care Medicine. Recurrent topics in Bonna Ith's work include Heme Oxygenase-1 and Carbon Monoxide (5 papers), Thermal Regulation in Medicine (3 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (2 papers). Bonna Ith is often cited by papers focused on Heme Oxygenase-1 and Carbon Monoxide (5 papers), Thermal Regulation in Medicine (3 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (2 papers). Bonna Ith collaborates with scholars based in United States, Taiwan and China. Bonna Ith's co-authors include Mark A. Perrella, Matthew D. Layne, Shaw‐Fang Yet, Xiaoli Liu, Yen‐Hsu Chen, Koji Maemura, Nicholas Sibinga, Konstantin Tsoyi, Joanne S. Ingwall and Mu-En Lee and has published in prestigious journals such as Circulation Research, American Journal of Respiratory and Critical Care Medicine and The FASEB Journal.

In The Last Decade

Bonna Ith

14 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bonna Ith United States 12 754 186 168 156 140 14 1.2k
Amie Traylor United States 21 868 1.2× 393 2.1× 151 0.9× 177 1.1× 129 0.9× 34 1.7k
Shivraj Tyagi United States 12 958 1.3× 209 1.1× 243 1.4× 297 1.9× 103 0.7× 17 1.5k
Reny Joseph United States 9 503 0.7× 94 0.5× 75 0.4× 106 0.7× 91 0.7× 10 877
Deborah Donohoe United States 12 336 0.4× 219 1.2× 79 0.5× 131 0.8× 68 0.5× 18 1.4k
C. Bruce Alexander United States 16 257 0.3× 282 1.5× 75 0.4× 65 0.4× 119 0.8× 29 1.0k
Ruiping Song United States 10 1.1k 1.5× 279 1.5× 24 0.1× 162 1.0× 141 1.0× 10 1.5k
Suzanne L. Advani Canada 26 914 1.2× 214 1.2× 82 0.5× 74 0.5× 156 1.1× 50 2.1k
Evis Harja United States 17 595 0.8× 258 1.4× 59 0.4× 176 1.1× 369 2.6× 20 2.0k
Alfonso Rubio‐Navarro Spain 19 407 0.5× 273 1.5× 50 0.3× 79 0.5× 140 1.0× 33 1.2k
Deron W. Jones United States 17 383 0.5× 161 0.9× 143 0.9× 71 0.5× 214 1.5× 30 1.0k

Countries citing papers authored by Bonna Ith

Since Specialization
Citations

This map shows the geographic impact of Bonna Ith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bonna Ith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bonna Ith more than expected).

Fields of papers citing papers by Bonna Ith

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bonna Ith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bonna Ith. The network helps show where Bonna Ith may publish in the future.

Co-authorship network of co-authors of Bonna Ith

This figure shows the co-authorship network connecting the top 25 collaborators of Bonna Ith. A scholar is included among the top collaborators of Bonna Ith based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bonna Ith. Bonna Ith is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Kwon, Min‐Young, Sailaja Ghanta, Julie Ng, et al.. (2021). Mesenchymal stromal cells expressing a dominant-negative high mobility group A1 transgene exhibit improved function during sepsis. Journal of Leukocyte Biology. 110(4). 711–722. 4 indexed citations
2.
Tsoyi, Konstantin, Xiaoliang Liang, Giulia De Rossi, et al.. (2021). CD148 Deficiency in Fibroblasts Promotes the Development of Pulmonary Fibrosis. American Journal of Respiratory and Critical Care Medicine. 204(3). 312–325. 38 indexed citations
3.
Chu, Sarah, Julian A. Villalba, Xiaoliang Liang, et al.. (2019). Palmitic Acid–Rich High-Fat Diet Exacerbates Experimental Pulmonary Fibrosis by Modulating Endoplasmic Reticulum Stress. American Journal of Respiratory Cell and Molecular Biology. 61(6). 737–746. 89 indexed citations
4.
Baron, Rebecca M., Ana P. Castaño, Sailaja Ghanta, et al.. (2018). Frontline Science: Targeted expression of a dominant-negative high mobility group A1 transgene improves outcome in sepsis. Journal of Leukocyte Biology. 104(4). 677–689. 11 indexed citations
5.
Ghanta, Sailaja, Konstantin Tsoyi, Xiaoli Liu, et al.. (2016). Mesenchymal Stromal Cells Deficient in Autophagy Proteins Are Susceptible to Oxidative Injury and Mitochondrial Dysfunction. American Journal of Respiratory Cell and Molecular Biology. 56(3). 300–309. 37 indexed citations
6.
Tsoyi, Konstantin, Sean R. R. Hall, Jesmond Dalli, et al.. (2016). Carbon Monoxide Improves Efficacy of Mesenchymal Stromal Cells During Sepsis by Production of Specialized Proresolving Lipid Mediators*. Critical Care Medicine. 44(12). e1236–e1245. 46 indexed citations
7.
Hall, Sean R. R., Konstantin Tsoyi, Bonna Ith, et al.. (2012). Mesenchymal Stromal Cells Improve Survival During Sepsis in the Absence of Heme Oxygenase-1: The Importance of Neutrophils. Stem Cells. 31(2). 397–407. 151 indexed citations
8.
Jiao, Wei, Xiaoli Liu, Bonna Ith, et al.. (2005). Increased Neointima Formation in Cysteine-Rich Protein 2–Deficient Mice in Response to Vascular Injury. Circulation Research. 97(12). 1323–1331. 50 indexed citations
9.
Ith, Bonna, Wei Jiao, Shaw‐Fang Yet, Mark A. Perrella, & Matthew D. Layne. (2004). Aortic carboxypeptidase-like protein is expressed in collagen-rich tissues during mouse embryonic development. Gene Expression Patterns. 5(4). 533–537. 27 indexed citations
10.
Yet, Shaw‐Fang, Matthew D. Layne, Xiaoli Liu, et al.. (2003). Absence of heme oxygenase‐1 exacerbates atherosclerotic lesion formation and vascular remodeling. The FASEB Journal. 17(12). 1759–1761. 247 indexed citations
11.
Ejima, Kuniaki, Matthew D. Layne, Irvith M. Carvajal, et al.. (2002). Modulation of the Thioredoxin System During Inflammatory Responses and Its Effect on Heme Oxygenase-1 Expression. Antioxidants and Redox Signaling. 4(4). 569–575. 24 indexed citations
12.
Layne, Matthew D., Shaw‐Fang Yet, Koji Maemura, et al.. (2002). Characterization of the Mouse Aortic Carboxypeptidase-Like Protein Promoter Reveals Activity in Differentiated and Dedifferentiated Vascular Smooth Muscle Cells. Circulation Research. 90(6). 728–736. 55 indexed citations
13.
Layne, Matthew D., Anand Patel, Yen‐Hsu Chen, et al.. (2001). Role of macrophage‐expressed adipocyte fatty acid binding protein in the development of accelerated atherosclerosis in hypercholesterolemic mice. The FASEB Journal. 15(14). 1–19. 55 indexed citations
14.
Yet, Shaw‐Fang, Rong Tian, Matthew D. Layne, et al.. (2001). Cardiac-Specific Expression of Heme Oxygenase-1 Protects Against Ischemia and Reperfusion Injury in Transgenic Mice. Circulation Research. 89(2). 168–173. 360 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026